Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human PLOD2 Protein, N-His

Catalog #:   YHA12801 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: O00469
Protein length: Asp37-Asn271
Overview

Catalog No.

YHA12801

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Asp37-Asn271

Predicted molecular weight

28.99 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

O00469

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

PLOD2, Lysyl hydroxylase 2, Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2, LH2

Data Image
  • SDS-PAGE
    SDS PAGE for Recombinant Human PLOD2 Protein
References

Comprehensive analysis of blood proteome response to necrotic enteritis in broiler chicken., PMID:40275387

Comprehensive analysis of glycometabolism-related genes reveals PLOD2 as a prognostic biomarker and therapeutic target in gastric cancer., PMID:40229676

Metabolism-related ALDH1B1 acts as potential predictor and therapeutic target for primary gastrointestinal diffuse large B-cell lymphoma., PMID:40216643

The Effect of Platelet-Rich Plasma on Synovial Fibrosis and Cartilage Degeneration in Knee Osteoarthritis., PMID:40114320

Anti-fibrotic effects of thrombin inhibition in systemic sclerosis-associated interstitial lung disease: Proof of concept., PMID:40013233

Knockdown of PLOD2 inhibits pulmonary artery smooth muscle cell glycolysis under chronic intermittent hypoxia via PI3K/AKT signal., PMID:39961468

Dysregulation of G6PD by HPV E6 exacerbates cervical cancer by activating the STAT3/PLOD2 pathway., PMID:39943705

Hypoxia-induced circPLOD2a/b promotes the aggressiveness of glioblastoma by suppressing XIRP1 through binding to HuR., PMID:39820362

Discovery of Glucose Metabolism-Associated Genes in Neuropathic Pain: Insights from Bioinformatics., PMID:39769264

Cellular and Molecular Effects of the Bruck Syndrome-Associated Mutation in the PLOD2 Gene., PMID:39769143

Hypoxia-induced translation of collagen-modifying enzymes PLOD2 and P4HA1 is dependent on RBM4 and eIF4E2 in human colon cancer HCT116 cells., PMID:39710969

Development and characterization of an in vitro fluorescently tagged 3D bone-cartilage interface model., PMID:39600948

Bmpr1aa modulates the severity of the skeletal phenotype in an fkbp10-deficient Bruck syndrome zebrafish model., PMID:39566080

PLOD2 exacerbates cervical squamous cell carcinoma by suppressing p53 by binding to YAP1., PMID:39513600

Clinical, genomic, and proteomic perspectives in the analysis of comorbid conditions in type 2 diabetes mellitus: a retrospective study., PMID:39508856

Hypoxia and Foxn1 alter the proteomic signature of dermal fibroblasts to redirect scarless wound healing to scar-forming skin wound healing in Foxn1-/- mice., PMID:39256768

Targeting PLOD2 suppresses invasion and metastatic potential in radiorecurrent prostate cancer., PMID:39184453

DNA methylation of bone morphogenetic protein 7 in leukocytes as a possible biomarker for hand osteoarthritis: A pilot study., PMID:39182186

Generation of bone-specific lysyl hydroxylase 2 knockout mice and their phenotypes., PMID:39156722

Gene-based association analysis of a large patient cohort provides insights into genetics of atypical femur fractures., PMID:39126371

Matricellular protein CCN1 promotes collagen alignment and scar integrity after myocardial infarction., PMID:39098433

Loss of the long form of Plod2 phenocopies contractures of Bruck syndrome-osteogenesis imperfecta., PMID:39088537

Systematic characterization of the expression, prognosis and immune characteristics of PLOD family genes in breast cancer., PMID:39068670

Effectiveness of whole exome sequencing analyses in the molecular diagnosis of osteogenesis imperfecta., PMID:38953412

Dissecting Crucial Gene Markers Involved in HPV-Associated Oropharyngeal Squamous Cell Carcinoma from RNA-Sequencing Data through Explainable Artificial Intelligence., PMID:38940026

DDX5 inhibits hyaline cartilage fibrosis and degradation in osteoarthritis via alternative splicing and G-quadruplex unwinding., PMID:38760576

Procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 promotes collagen cross-linking and ECM stiffening to induce liver fibrosis., PMID:38696846

A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma., PMID:38656879

Exome sequencing identified mutations in the WNT1 and COL1A2 genes in osteogenesis imperfecta cases., PMID:38536562

The HIF-1α/PLOD2 axis integrates extracellular matrix organization and cell metabolism leading to aberrant musculoskeletal repair., PMID:38472175

Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement., PMID:38462571

Sarcoma Cells Secrete Hypoxia-Modified Collagen VI to Weaken the Lung Endothelial Barrier and Promote Metastasis., PMID:38335278

METTL3 facilitates renal cell carcinoma progression by PLOD2 m6A-methylation under prolonged hypoxia., PMID:38233403

Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literature., PMID:38114270

Development and validation of a combined hypoxia- and metabolism-related prognostic signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma., PMID:38023248

Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation., PMID:38008826

Identification of Potential Genes and Critical Pathways in Postoperative Recurrence of Crohn's Disease by Machine Learning And WGCNA Network Analysis., PMID:37994325

Circ-Plod2 destabilizes Mpo mRNA by binding to IGF2BP2 to promote osteogenic differentiation of bone marrow mesenchymal stem cells., PMID:37981258

Mmp14 is required for matrisome homeostasis and circadian rhythm in fibroblasts., PMID:37913834

N6-methyladenosine modification of PLOD2 causes spermatocyte damage in rats with varicocele., PMID:37670228

Minoxidil weakens newly synthesized collagen in fibrotic synoviocytes from osteoarthritis patients., PMID:37605092

Circular RNA circPLOD2 regulates pericyte function by targeting the transcription factor KLF4., PMID:37481725

tDCS Regulates ASBT-3-OxoLCA-PLOD2-PTEN Signaling Pathway to Confer Neuroprotection Following Rat Cerebral Ischemia-Reperfusion Injury., PMID:37477767

Influence of the concentrate inclusion level in a grass silage-based diet on hepatic transcriptomic profiles in Holstein-Friesian dairy cows in early lactation., PMID:37474362

Prognostic model based on telomere-related genes predicts the risk of oral squamous cell carcinoma., PMID:37452322

Integrative transcriptome and proteome analyses of clear cell renal cell carcinoma develop a prognostic classifier associated with thrombus., PMID:37328520

Validation of Fourier Transform Infrared Microspectroscopy for the Evaluation of Enzymatic Cross-Linking of Bone Collagen., PMID:37278762

Exploration and validation of the hub genes involved in hypoxia-induced endothelial-mesenchymal transition of systemic sclerosis., PMID:37246768

PLOD2 promotes colorectal cancer progression by stabilizing USP15 to activate the AKT/mTOR signaling pathway., PMID:37227305

The PLOD2/succinate axis regulates the epithelial-mesenchymal plasticity and cancer cell stemness., PMID:37155842

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human PLOD2 Protein, N-His [YHA12801]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only